These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmaceutical and therapeutic applications of artificial cells including microencapsulation. Chang TM Eur J Pharm Biopharm; 1998 Jan; 45(1):3-8. PubMed ID: 9689530 [TBL] [Abstract][Full Text] [Related]
9. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer. Günzburg WH; Salmons B Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235 [TBL] [Abstract][Full Text] [Related]
10. Coated charcoal haemoperfusion. Chang TM Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672 [TBL] [Abstract][Full Text] [Related]
12. Artificial cells in hemoperfusion and other applications. Chang TM Nephron; 1984; 36(3):161-8. PubMed ID: 6366599 [TBL] [Abstract][Full Text] [Related]
13. Present status of modified hemoglobin as blood substitutes and oral therapy for end stage renal failure using artificial cells containing genetically engineered cells. Chang TM Ann N Y Acad Sci; 2001 Nov; 944():362-72. PubMed ID: 11797686 [TBL] [Abstract][Full Text] [Related]
14. Applications of artificial cells in medicine and biotechnology. Chang TM Biomater Artif Cells Artif Organs; 1987; 15(1):1-20. PubMed ID: 3329537 [TBL] [Abstract][Full Text] [Related]
15. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists. Chang TM Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657 [TBL] [Abstract][Full Text] [Related]
17. Artificial cells in medicine and biotechnology. Chang TM Appl Biochem Biotechnol; 1984; 10():5-24. PubMed ID: 6395808 [TBL] [Abstract][Full Text] [Related]
18. Encapsulated, genetically modified cells producing in vivo therapeutics. Hauser O; Prieschl-Grassauer E; Salmons B Curr Opin Mol Ther; 2004 Aug; 6(4):412-20. PubMed ID: 15468600 [TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
20. The dawn of biotechnology in artificial organs. Galletti PM; Aebischer P; Lysaght MJ ASAIO J; 1995; 41(1):49-57. PubMed ID: 7727822 [No Abstract] [Full Text] [Related] [Next] [New Search]